CENTENE CORP (CNC)

Current Report Filed: 2026-05-15

Key Insights

All nine director nominees were successfully elected with strong shareholder support, with most receiving over 87% approval votes, indicating investor confidence in the board composition.
Executive compensation received substantial shareholder approval (91.6% of votes cast in favor), suggesting shareholders are satisfied with management's pay structure and performance alignment.
The shareholder proposal requesting an independent board chairman was decisively rejected with 80.5% voting against it, demonstrating shareholders prefer the current leadership structure where the CEO and board chair roles may be combined.
KPMG LLP was ratified as the independent auditor with overwhelming support (94.5% approval), indicating continued confidence in the company's audit and financial controls.
New executive appointments of Daniel Finke and Michael Carson as Group Presidents for Medicaid/Marketplace and Medicare/Specialty respectively signal organizational restructuring to improve operational focus across key business segments.

Insider Trading Filed: 2026-05-13

Key Insights

Director Kenneth Tanji acquired 3,992 restricted stock units (RSUs) on 05/12/2026 at no cost, increasing his beneficial ownership to 11,909 shares, indicating equity compensation aligned with director role.
RSUs will vest in full on the earlier of May 12, 2027 or the next annual meeting of stockholders, representing a standard one-year vesting schedule for director compensation.
The acquisition was executed by attorney-in-fact Christopher A. Koster on 05/13/2026, one day after the transaction date, suggesting routine administrative processing of director equity grants.

Insider Trading Filed: 2026-05-13

Key Insights

Director Theodore R. Samuels II acquired 3,992 restricted stock units (RSUs) on 05/12/2026 at no cost, vesting in full by May 12, 2027, representing standard equity compensation for board service.
Total beneficial ownership increased to approximately 24,748 shares directly owned plus 32,000 shares indirectly held through a family trust, indicating meaningful personal stake in company performance.
The RSU grant with near-term vesting (approximately 1 year) suggests confidence in company direction, though the modest acquisition size and compensatory nature indicate routine board compensation rather than significant insider conviction.
Filing executed by attorney-in-fact Christopher A. Koster on 05/13/2026, one day after transaction date, demonstrating standard compliance procedures with no irregularities noted.

Insider Trading Filed: 2026-05-13

Key Insights

Director Monte E. Ford acquired 3,992 shares of restricted stock units (RSUs) on 05/12/2026 at no cost, bringing total beneficial ownership to 14,826.771 shares, indicating routine equity compensation rather than open market purchases.
The RSUs vest on the earlier of May 12, 2027, or the next annual stockholders meeting, representing standard director compensation with a one-year vesting schedule typical for board members.
The transaction was executed by attorney-in-fact Christopher A. Koster and filed on 05/13/2026, showing normal administrative processing of equity awards with no signs of abnormal insider activity or timing concerns.

Insider Trading Filed: 2026-05-13

Key Insights

Director Frederick H. Eppinger acquired 6,654 restricted stock units (RSUs) at $0 cost on 05/12/2026, representing a non-cash compensation award typical of director compensation practices.
The RSUs will vest in full on the earlier of May 12, 2027, or the next annual stockholder meeting, indicating a one-year vesting period standard for board-level equity awards.
Eppinger's total beneficial ownership following this transaction is 368,704.658 shares, demonstrating substantial long-term alignment with shareholder interests as a director.

Insider Trading Filed: 2026-05-13

Key Insights

Director Dallas H James acquired 3,992 restricted stock units (RSUs) on May 12, 2026, with full vesting scheduled for May 12, 2027, representing a standard equity compensation award rather than discretionary insider buying.
James holds 47,874.185 shares directly following this transaction, indicating a meaningful personal stake in Centene, though the RSU acquisition at $0 price reflects compensation rather than market-based investment conviction.
An additional 1,693 shares are held indirectly through a revocable family trust where James serves as co-trustee, bringing total beneficial ownership to approximately 49,567 shares, demonstrating established long-term commitment to the company.

Insider Trading Filed: 2026-05-13

Key Insights

Director Christopher Coughlin acquired 3,992 restricted stock units (RSUs) on 05/12/2026 at $0 price, indicating a standard equity compensation award vesting over one year, demonstrating normal director compensation practices.
Coughlin's total beneficial ownership increased to approximately 48,147 shares (18,149 directly owned plus 30,054 held indirectly through a grantor retained annuity trust), showing meaningful long-term alignment with shareholder interests.
The RSU grant vesting structure (May 12, 2027 or next annual meeting) is typical for board compensation and creates incentive alignment without suggesting any material insider trading activity or concerning patterns.

Insider Trading Filed: 2026-05-13

Key Insights

Director Kenneth Burdick acquired 3,992 restricted stock units on 05/12/2026 at $0 price, representing a standard equity compensation grant that will vest on 05/12/2027 or the next annual meeting.
Burdick's direct beneficial ownership increased to 277,085.924 shares following this transaction, with an additional 86,498 shares held indirectly through Burdick Family LLC.
The filing shows routine insider compensation activity with no material stock sales or concerning liquidation patterns, suggesting confidence in the company's prospects by senior management.

Insider Trading Filed: 2026-05-13

Key Insights

Director Jessica L. Blume acquired 3,992 shares of restricted stock units (RSUs) on 05/12/2026 at no cost, vesting in full by May 12, 2027, representing a standard equity compensation grant rather than discretionary insider buying.
Blume's total beneficial ownership is 32,357 shares directly held plus 250 shares indirectly owned through a revocable family trust, indicating modest equity stake and limited insider conviction signal.
The filing shows only compensation-related equity activity with no open market purchases or sales, suggesting no material insider views on stock valuation at current levels.

Current Report Filed: 2026-04-28

Key Insights

Centene announced Q1 2026 financial results on April 28, 2026, with the full press release attached as Exhibit 99.1, providing investors with detailed operational and earnings performance data.
The 8-K filing is a standard earnings announcement with no material agreements, executive changes, or significant corporate events disclosed, indicating routine quarterly reporting.
As a managed healthcare company, Q1 results would typically reflect key metrics such as membership trends, medical loss ratios, and operational efficiency, though specific numbers are not detailed in this cover filing.

Quarterly Report Filed: 2026-04-28

Key Insights

The filing is dated April 28, 2026 for Q1 2026 (ending March 31, 2026), showing Centene Corp continuing operations as a major managed care provider with exposure to healthcare premium members and service members.
The presence of Magellan Health as a held-for-sale asset (marked as disposal group not discontinued operations) indicates ongoing strategic portfolio management and potential divestiture activity that could impact future revenue composition.
The company maintains a diversified investment portfolio across multiple security types (US Treasuries, corporate bonds, municipal bonds, mortgage-backed securities) with fair value measurements across multiple levels, suggesting active treasury management and strong liquidity position.

Insider Trading Filed: 2026-04-16

Key Insights

The Chief People Officer, Tanya M. McNally, reported selling 964 shares of Centene Corporation (CNC) common stock on April 15, 2026, at a price of $37.26 per share.
After the transaction, McNally continues to beneficially own 127,258 shares, including 112,054 shares from previously granted restricted stock units and performance stock units.
The sale of shares appears to be related to a tax withholding event upon the vesting of the restricted stock units, a common practice for executives to cover tax obligations.

Insider Trading Filed: 2026-03-31

Key Insights

Christopher Coughlin, a director of Centene Corporation, acquired 1,140 shares of common stock on March 31, 2026 at no cost, increasing his direct ownership to 14,156.926 shares.
Coughlin also holds an indirect ownership of 30,054 shares through a grantor retained annuity trust, for which he is the sole trustee.
The acquisition of shares by a director suggests potential confidence in the company's future prospects.

Insider Trading Filed: 2026-03-31

Key Insights

Kenneth Tanji, a director of Centene Corporation, acquired 1,179 shares of common stock on March 31, 2026, increasing his direct beneficial ownership to 7,917 shares, which includes 3,579 shares of restricted stock units subject to vesting requirements.
The transaction suggests that Tanji has confidence in the company's future prospects and is willing to increase his stake in the organization.
Investors should monitor insider trading activities, as they can provide valuable insights into management's perspective on the company's outlook and potential growth opportunities.

Insider Trading Filed: 2026-03-31

Key Insights

Insider Theodore R. Samuels II, a director at Centene Corporation, acquired 943 shares of the company's common stock on March 31, 2026 at $0 per share.
Samuels also owns an additional 32,000 shares of Centene through a family trust, indicating continued confidence in the company's prospects.
The acquisition of nearly 1,000 shares at no cost suggests Samuels may have received the shares as part of a compensation or incentive plan, aligning his interests with those of Centene's shareholders.

Insider Trading Filed: 2026-03-31

Key Insights

The reporting person, Frederick H. Eppinger, acquired 1,690 shares of Centene Corporation (CNC) common stock at $0 per share, increasing their direct beneficial ownership to 362,050.658 shares.
Eppinger holds 5,965 shares of restricted stock units subject to vesting requirements, indicating potential future ownership changes.
The transaction was executed on March 31, 2026, suggesting ongoing insider investment in the company.

Current Report Filed: 2026-03-24

Key Insights

Centene Corporation has appointed Theodore Pienkos as their new Corporate Controller and Chief Accounting Officer, signaling a leadership transition within the company's finance function.
Kate Casso, the previous Corporate Controller, has been appointed to the role of Senior Vice President, Finance Operations and Innovation, indicating a focus on finance operations and innovation.
The company's intentional leadership development approach is highlighted, with internal talent being elevated to key positions.

Insider Trading Filed: 2026-03-17

Key Insights

Susan Raye Smith, the Chief Operating Officer of Centene Corporation, disposed of 2,918 shares of common stock through a tax withholding transaction, reducing her direct ownership to 212,720 shares.
Smith continues to hold a significant equity position in Centene, including 182,815 shares from previously granted restricted stock units and performance stock units.
The transaction appears to be a routine tax withholding event and does not indicate any major changes in Smith's ownership or the company's leadership.

Insider Trading Filed: 2026-03-17

Key Insights

Tanya M. McNally, the Chief People Officer, disposed of 2,785 shares of Centene Corp (CNC) common stock through a share withholding transaction for tax purposes.
Following the reported transaction, McNally still beneficially owns 128,222 shares, including 114,503 shares of previously-granted restricted stock units and performance stock units.
The share disposition appears to be a routine tax-related transaction and does not indicate a major change in McNally's overall ownership or position with the company.

Insider Trading Filed: 2026-03-17

Key Insights

Insider Sarah London, Chief Executive Officer, has sold 36,061 shares of Centene Corp (CNC) stock, likely for tax purposes related to vesting of restricted stock units.
London still maintains a substantial ownership stake of 1,188,831 shares, including unvested restricted stock units and performance stock units, indicating continued alignment with shareholders.
Centene granted London a performance-based stock option in December 2021, which can become exercisable if the company's stock price reaches $100 per share for 20 consecutive trading days.

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Important Information